In addition to utilizing 4-1BB as a costimulatory target, other BsAbs called bispecific T-cell engager (BiTE) antibodies link antigens on tumor cells to CD3 on T-cells, which activates T-cell receptor (TCR) complexes and initiates apoptosis [58,59,60]. The gene discussed is TNFRSF9; the disease is neoplasm.